International Society for the Study of Women's Sexual Health

ISSWSH Annual Meeting
February 25-28, 2016


Charleston, SC - USA
Charleston Marriot

ISSWSH is a multidisciplinary, academic, and scientific organization whose purposes are:

To provide

opportunities for communication among scholars, researchers, and practitioners about women's sexual function and sexual experience...

To support

the highest standards of ethics and professionalism in research, education, and clinical practice of women's sexuality, and ...

To provide

the public with accurate information about women's sexuality and sexual health.

UPCOMING MEETINGS

ISSWSH Fall Course 2015

October 9-11, 2015   37 days left
DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...
Register Now!

ISSWSH Annual Meeting 2016

  February 25-28, 2016   176 days left
  Marriott, Charleston, SC - USA
Register Now!

LATEST NEWS

Flibanserin approved as the FIRST pharmacologic treatment option for women suffering from hypoactive sexual desire disorder
  PUBLISHED: TUESDAY, AUGUST 18, 2015

Dear ISSWSH members,

It is with tremendous excitement that we share the announcement that flibanserin, a drug for acquired, generalized hypoactive sexual desire disorder (HSDD) developed by Sprout Pharmaceuticals, was approved by the FDA on August 18, 2015. This follows the June 4, 2015 meeting of their Advisory Committee whose members voted 18-6 for approval.

Read more ...
Flibanserin recommended for approval by the FDA Advisory Committee Panel
  PUBLISHED: FRIDAY, JUNE 05, 2015

Dear ISSWSH members,
It is with great excitement that I share the announcement that flibanserin, a drug for hypoactive sexual desire disorder (HSDD) developed by Sprout Pharmaceuticals, was recommended for approval by the FDA Advisory Committee Panel on June 4, 2015.

Read more ...
General Statement of the International Society for the Study of Women's Sexual Health
  PUBLISHED: FRIDAY, MAY 08, 2015

The International Society for the Study of Women's Sexual Health (ISSWSH), the preeminent scientific organization focused on research, education, and clinical practice of women's sexuality, applauds the FDA's recent announcement of it's upcoming Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee on June 4, 2015.

Read more ...

Latest Tweets

Don’t' forget to register for the 2015 ISSWSH Fall Course from October 9-11, 2015 http://t.co/mQ5OQ7Aa0E ISSWSH
ISSWSH Advocacy Chair declares Addyi’s approval a sexual health advancement http://t.co/fRwuG3EJI8 ISSWSH
Some #couples report that #infertility treatments stress #relationship; others report it brings them closer http://t.co/tZzDqO15Y2 ISSWSH

Contact Details

ISSWSH Executive Office - Status Plus LLC
PO Box 160
Holly Ridge NC 28445
USA

Phone: +1 (218) 461-5115
Fax: +1 (910) 778-2586
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.